Arthex Biotech closes a €42M Series B financing round

Japan’s strengths in research present a major opportunity for scaling biotechnology start-ups. To address the challenge of limited access to entrepreneurship coaching and capital hindering global expansion, the Japan Society of Northern California (JSNC) and OviBees Ventures are implementing bioJent, a one-year entrepreneurship support program to build cultural and business ties between the U.S. and Japan, with a focus on venture capital and entrepreneurship coaching in the biotechnology sector.